rs41277434

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004456.5(EZH2):​c.2110+6T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0569 in 1,600,172 control chromosomes in the GnomAD database, including 3,257 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 290 hom., cov: 33)
Exomes 𝑓: 0.058 ( 2967 hom. )

Consequence

EZH2
NM_004456.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0003168
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.791

Publications

27 publications found
Variant links:
Genes affected
EZH2 (HGNC:3527): (enhancer of zeste 2 polycomb repressive complex 2 subunit) This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011]
EZH2 Gene-Disease associations (from GenCC):
  • Weaver syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 7-148809304-A-C is Benign according to our data. Variant chr7-148809304-A-C is described in ClinVar as Benign. ClinVar VariationId is 137273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EZH2NM_004456.5 linkc.2110+6T>G splice_region_variant, intron_variant Intron 18 of 19 ENST00000320356.7 NP_004447.2 Q15910-2A0A090N8E9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EZH2ENST00000320356.7 linkc.2110+6T>G splice_region_variant, intron_variant Intron 18 of 19 1 NM_004456.5 ENSP00000320147.2 Q15910-2

Frequencies

GnomAD3 genomes
AF:
0.0503
AC:
7661
AN:
152232
Hom.:
286
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0192
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.0571
Gnomad EAS
AF:
0.0373
Gnomad SAS
AF:
0.0457
Gnomad FIN
AF:
0.0662
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0547
Gnomad OTH
AF:
0.0545
GnomAD2 exomes
AF:
0.0682
AC:
17153
AN:
251348
AF XY:
0.0651
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.182
Gnomad ASJ exome
AF:
0.0587
Gnomad EAS exome
AF:
0.0360
Gnomad FIN exome
AF:
0.0690
Gnomad NFE exome
AF:
0.0526
Gnomad OTH exome
AF:
0.0692
GnomAD4 exome
AF:
0.0576
AC:
83363
AN:
1447822
Hom.:
2967
Cov.:
31
AF XY:
0.0571
AC XY:
40944
AN XY:
716946
show subpopulations
African (AFR)
AF:
0.0174
AC:
580
AN:
33298
American (AMR)
AF:
0.173
AC:
7704
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.0599
AC:
1559
AN:
26040
East Asian (EAS)
AF:
0.0526
AC:
2066
AN:
39284
South Asian (SAS)
AF:
0.0459
AC:
3948
AN:
85962
European-Finnish (FIN)
AF:
0.0665
AC:
3542
AN:
53290
Middle Eastern (MID)
AF:
0.0826
AC:
474
AN:
5738
European-Non Finnish (NFE)
AF:
0.0546
AC:
60068
AN:
1099912
Other (OTH)
AF:
0.0573
AC:
3422
AN:
59756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
3537
7074
10612
14149
17686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2330
4660
6990
9320
11650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0503
AC:
7663
AN:
152350
Hom.:
290
Cov.:
33
AF XY:
0.0511
AC XY:
3805
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0191
AC:
794
AN:
41582
American (AMR)
AF:
0.109
AC:
1666
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0571
AC:
198
AN:
3470
East Asian (EAS)
AF:
0.0370
AC:
192
AN:
5192
South Asian (SAS)
AF:
0.0456
AC:
220
AN:
4828
European-Finnish (FIN)
AF:
0.0662
AC:
703
AN:
10616
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0547
AC:
3721
AN:
68036
Other (OTH)
AF:
0.0539
AC:
114
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
374
749
1123
1498
1872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0556
Hom.:
222
Bravo
AF:
0.0552
Asia WGS
AF:
0.0570
AC:
199
AN:
3478
EpiCase
AF:
0.0579
EpiControl
AF:
0.0561

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 07, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 19, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Weaver syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
18
DANN
Benign
0.67
PhyloP100
0.79
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00032
dbscSNV1_RF
Benign
0.040
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41277434; hg19: chr7-148506396; COSMIC: COSV57446454; COSMIC: COSV57446454; API